Based on the function of ZHX2 as a transcriptional repressor and its known interaction with NF-YA, we hypothesized that ZHX2 might inhibit MDR1 expression in liver cancer cells, resulting in reduced efflux of chemotherapeutic drugs and subsequent increased sensitivity to these agents. The gene discussed is ABCB1; the disease is liver cancer.